Name of Trial/NCT#:Â IvoLoC Trial: A Phase II Trial Evaluating the Efficacy of Ivonescimab in Metastatic Endocrine Refractory HR-positive HER2-negative or Triple Negative Invasive Lobular […]
 LBCA is offering a limited number of travel scholarship grants for patient advocates interested in Invasive Lobular Carcinoma (ILC) education and research advocacy to attend
LBCA Travel Grant Scholarship Program – SABCS 2026 Application Read More »
My name is Jen, and I live in London, Ontario. I’m a consultant, a certified coach, and a co-founder of a government tech startup. I
Jen Shares her Story with Lobular Breast Cancer Read More »
Dr. Gary Ulaner elected President of the Society of Nuclear Medicine and Molecular Imaging Congratulations to LBCA Scientific Advisory Board member, Dr. Gary Ulaner on
LBCA Patient Advocate Advisory Board member, and ILC patient advocate Jade Moran helped put lobular breast cancer front and center at the 2026 Annual Meeting
New Local Advocacy Team Launches in Michigan! LBCA’s fourth Local Advocacy Team (LAT) has launched in Michigan and will be run by LBCA LAT Ambassadors
New Local Advocacy Team Launches in Michigan! Read More »
Following the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting, LBCA sat down with Dr. Julie Sutcliffe, Professor at the University of California,
New Imaging Research Offers Hope for Detecting and Treating Lobular Breast Cancer Read More »
The American Society of Clinical Oncology (ASCO) annual conference convenes oncology professionals worldwide to share the latest cancer research and shape cancer care. LBCA has
A Collection of Lay Summaries from ASCO 2026 Read More »
The 2026 Annual Society of Clinical Oncology’s (ASCO’s) annual meeting, always held at McCormick Place (on the Lake) in Chicago, attracted 46,000 medical professionals, research
Dr. Julie Sutcliffe, professor of internal medicine and biomedical engineering at the University of California, Davis received a $500,000 grant from the 2023 Society of
ILC Research Update from SNMMI Mars Shot Awardee Dr. Julie Sutcliffe Read More »
Thanks to the $1 Million gift made by Dr. Shannon Klingman, physician, lobular breast cancer survivor, and founder of Lume Deodorant, LBCA has launched a
LBCA SAB Member, Dr. Rinath Jeselsohn gave a Keynote Lecture at the ESMO Breast Cancer annual congress in Berlin, Germany on May 5, 2026, “Lobular
Since 2021, when LBCA issued the first grant solicitation for ILC research in history, LBCA has funded thirteen ILC focused research grants, and committed funding
LBCA is Making Waves for ILC Research Read More »
When Julie Ray was diagnosed with invasive lobular carcinoma in the summer of 2023, she had never heard that breast cancer had types. Three years
LBCA was recently privileged to to share ILC information with patients and caregivers at Living Beyond Breast Cancer’s 2026 Conference on Metastatic Breast Cancer, which
Advocacy in Action: LBCA Advocates Attend Living Beyond Breast Cancer 2026 Read More »
"*" indicates required fields
